Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 1 results
Sort by: relevance publication year

Final overall survival analysis and organ-specific target lesion assessments with two-year follow-up in CheckMate 9ER: Nivolumab plus cabozantinib versus sunitinib for patients with advanced renal cell carcinoma.

JOURNAL ARTICLE published 20 February 2022 in Journal of Clinical Oncology

Authors: Thomas Powles | Toni K. Choueiri | Mauricio Burotto | Bernard Escudier | Maria Teresa Bourlon | Amishi Yogesh Shah | Cristina Suárez | Alketa Hamzaj | Camillo Porta | Christopher Hocking | Elizabeth R Kessler | Howard Gurney | Yoshihiko Tomita | Jens Bedke | Joshua Zhang | Burcin Simsek | Christian Scheffold | Andrea B. Apolo | Robert J. Motzer